These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36036169)

  • 1. Bazedoxifene plus conjugated estrogens improve menopausal symptoms in postmenopausal women: a systematic review and meta-analysis.
    Bi B; Jiang Y; Shi Y; Ruan F
    Gynecol Endocrinol; 2022 Oct; 38(10):813-821. PubMed ID: 36036169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women.
    Utian W; Yu H; Bobula J; Mirkin S; Olivier S; Pickar JH
    Maturitas; 2009 Aug; 63(4):329-35. PubMed ID: 19647382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect effects of conjugated estrogens/bazedoxifene treatment on quality of life in postmenopausal women.
    Abraham L; Bushmakin AG; Dragon E; Komm BS; Pinkerton JV
    Maturitas; 2016 Dec; 94():173-179. PubMed ID: 27823739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials.
    Archer DF; Freeman EW; Komm BS; Ryan KA; Yu CR; Mirkin S; Pinkerton JV
    J Womens Health (Larchmt); 2016 Nov; 25(11):1102-1111. PubMed ID: 27676118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.
    Pinkerton JV; Utian WH; Constantine GD; Olivier S; Pickar JH
    Menopause; 2009; 16(6):1116-24. PubMed ID: 19546826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population.
    Palacios S; Arias L; Lavenberg J; Pan K; Mirkin S; Komm BS
    Climacteric; 2016 Jun; 19(3):261-7. PubMed ID: 26940720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.
    Pinkerton JV; Abraham L; Bushmakin AG; Cappelleri JC; Racketa J; Shi H; Chines AA; Mirkin S
    J Womens Health (Larchmt); 2014 Jan; 23(1):18-28. PubMed ID: 24206058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
    Lobo RA; Pinkerton JV; Gass MLS; Dorin MH; Ronkin S; Pickar JH; Constantine G
    Fertil Steril; 2009 Sep; 92(3):1025-1038. PubMed ID: 19635615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens: a randomized trial.
    Pinkerton JV; Pan K; Abraham L; Racketa J; Ryan KA; Chines AA; Mirkin S
    Menopause; 2014 Mar; 21(3):252-9. PubMed ID: 23942245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.
    Bachmann G; Bobula J; Mirkin S
    Climacteric; 2010 Apr; 13(2):132-40. PubMed ID: 19863455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the direct and indirect effects of bazedoxifene/conjugated estrogens on sleep disturbance using mediation modeling.
    Pinkerton JV; Bushmakin AG; Racketa J; Cappelleri JC; Chines AA; Mirkin S
    Menopause; 2014 Mar; 21(3):243-51. PubMed ID: 23899830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hot flush symptom-free days with bazedoxifene/conjugated estrogens in postmenopausal women.
    Yu H; Racketa J; Chines AA; Mirkin S
    Climacteric; 2013 Apr; 16(2):252-7. PubMed ID: 23035721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Palacios S; Currie H; Mikkola TS; Dragon E
    Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
    Komm BS; Mirkin S; Jenkins SN
    Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.
    Abraham L; Pinkerton JV; Messig M; Ryan KA; Komm BS; Mirkin S
    Maturitas; 2014 Jul; 78(3):212-8. PubMed ID: 24837362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trials.
    Pinkerton JV; Pickar JH; Ryan KA; Yu CR; Mirkin S; Komm BS
    Menopause; 2016 Jun; 23(6):611-20. PubMed ID: 27163519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective estrogen modulators in menopause.
    Gambacciani M
    Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the measurement model and clinically important differences for menopause-specific quality of life associated with bazedoxifene/conjugated estrogens.
    Bushmakin AG; Abraham L; Pinkerton JV; Cappelleri JC; Mirkin S
    Menopause; 2014 Aug; 21(8):815-22. PubMed ID: 24378765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
    Pinkerton JV; Pickar JH; Racketa J; Mirkin S
    Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.